Prescription records of blood anti-coagulants
Thank you for your request dated 4 September 2023 under the Official Information Act 1982 (OIA) for information relating to dabigatran, rivaroxaban and bisoprolol. You requested:
Please supply monthly and quarterly records of prescriptions for Dabigatran 20mg from August 1, 2018 - August 1, 2023.
Please supply monthly and quarterly records for prescriptions for Rivaroxaban 20mg since Pharmac funded the medicine for prescription, or from August 1, 2018 - August 1, 2023.
Please also provide monthly and quarterly records for prescriptions for bisoprolol 2.5mg from August 1, 2018 - August 1, 2023
We are pleased to provide you with the information for your request in the excel spreadsheet attached.
As there is no 20mg formulation for the chemical name dabigatran, we have included all formulations of dabigatran.
We trust that this information answers your queries. Please note, you have the right to make a complaint to the Ombudsman about our response to your OIA, under section 28(3) of the OIA. Details of how to make a complaint(external link) are on the Ombudsman’s website.
To make information more freely available, we publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.